Daiichi Sankyo Co Ltd - Company & Market Research Reports

Home /
Companies /
Daiichi Sankyo Co Ltd

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 111
Cardiovascular Drugs 86
Vaccines 47
Central Nervous System Drugs 38
Pharmaceuticals 34
Hematological Drugs 34
Drug Discovery 33
Endocrine and Metabolic Disorders Drugs 31
Immune Disorders Drugs 27
Genomics 25
Musculoskeletal Disorders Drugs 25
Leukemia Drugs 24
Analgesics 23
Biopharmaceuticals 23
Clinical Trials 21
Infectious Diseases Drugs 20
Contrast Media 19
Oncology 17
Biotechnology 15
Skin Cancer Drugs 15
Lung Cancer Drugs 14
Infusions and Injectables 14
Antibiotics 14
Women's Health 13
Enzymes 13
Breast Cancer Drugs 12
Alzheimer's Disease Drugs 12
Diabetes Drugs 11
Liver and Kidney Disorders Drugs 11
Brain Cancer Drugs 10
Hematology 10
Diagnostics 9
Gastrointestinal Drugs 9
Respiratory Drugs 9
Allergy and Immunology 8
Healthcare Services 8
Biosimilars and Biosuperiors 8
Colon Cancer Drugs 7
Ultrasound 6
Cardiology 6
Urological Disorders Drugs 6
Pharmaceutical Manufacturing 6
Animal Pharmaceuticals 5
Optical Disorders Drugs 5
Lymphoma Drugs 5
Managed Care 5
Stem Cells 5
Thyroid Cancer Drugs 5
Pharmaceutical Intermediates 4
Pulmonary Medicine 4
Neurology 4
Liver Cancer Drugs 4
Ovarian Cancer Drugs 4
Cervical Cancer Drugs 4
In Vitro Diagnostics 4
Infectious Disease Testing 4
Medical Devices 4
Drug Delivery 4
Gastroenterology 4
Dermatological Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Transdermal and Transmucosal Drug Delivery 3
Pancreatic Cancer Drugs 3
Pediatrics 3
HIV/AIDS Drugs 3
Company Reports 2
Therapeutic Area 2
Urology and Nephrology 2
Prostate Cancer Drugs 2
Cardiovascular Devices 2
Blood Banking 2
Anesthetic Drugs 2
Needles and Syringes 2
Neurology Devices 2
Over the Counter (OTC) Drugs 2
Nuclear Medicine and Radiopharmacology 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Anti-Obesity Drugs 2
Palliative Care 2
Bronchitis Drugs 2
Patient Monitoring Equipment 1
Pharmacoeconomics 1
Bladder Cancer Drugs 1
Proteomics 1
Medical Imaging 1
Hospital Information Systems 1
Coagulation and Hemostasis Testing 1
Healthcare 1
Dental 1
Magnetic Resonance Imaging (MRI) 1
Radiography 1
Optical 1
Hospital Management 1
Biomarkers 1
Dermatology 1
Surgical Procedures 1
Molecular Diagnostics 1
Catheters 1
Mental Disorders Drugs 1
Uterine Cancer Drugs 1
Other Healthcare Facilities 1
Nanomedicine 1
Laboratory Equipment 1
Endocrinology 1
Acne Drugs 1
Asthma Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

765 Results (Page 27 of 39)
- Relevance
  Sort by

Myelodysplastic Syndrome Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4163EUR$4,490USD£3,482GBP

Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)

 Report
January 2025
388 Pages
Global

From

€2494EUR$2,690USD£2,086GBP

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1854EUR$2,000USD£1,551GBP

Preventable Vaccines - Global Strategic Business Report 2026

 Report
November 2026
391 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

Inactivated Polio and Rabies Vaccines - Global Strategic Business Report

 Report
November 2026
470 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Inactivated Vaccines - Global Strategic Business Report

 Report
November 2026
468 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

Bacterial Vaccines - Global Strategic Business Report

 Report
November 2026
490 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

Adult Vaccines - Global Strategic Business Report

 Report
November 2026
377 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

Adenovirus Vaccines - Global Strategic Business Report

 Report
November 2026
279 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Regional Outlook and Forecast, 2022 - 2028

 Report
May 2022
188 Pages
Global

From

€3338EUR$3,600USD£2,792GBP

Mumps Vaccines - Global Strategic Business Report

 Report
November 2026
288 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

COVID-19 Vaccines - Global Strategic Business Report

 Report
November 2026
762 Pages
Global

From

€5377EUR$5,800USD£4,498GBP

Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035

 Report
February 2023
243 Pages
Asia Pacific

From

€5146EUR$5,550USD£4,304GBP

Stem Cell Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
120 Pages
Global

From

€4404EUR$4,750USD£3,684GBP

Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028

 Report
September 2025
120 Pages
Global

From

€2596EUR$2,800USD£2,171GBP

Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2024-2028

 Report
December 2023
160 Pages
Global

From

€2318EUR$2,500USD£1,939GBP

Acute Myeloid Leukemia (AML) Treatment Market in Apac 2026-2030

 Report
January 2026
192 Pages
Asia Pacific

From

€2318EUR$2,500USD£1,939GBP

Companion Animal Postoperative Pain Management Therapeutics - Global Strategic Business Report 2026

 Report
November 2026
474 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

Combination Vaccines - Global Strategic Business Report 2026

 Report
November 2026
373 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

Influenza Vaccines - Global Strategic Business Report 2026

 Report
November 2026
554 Pages
Global

From

€5424EUR$5,850USD£4,537GBP

765 Results (Page 27 of 39)
- 1
- 25
- 26
- 27
- 28
- 29

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.